Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Topotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 17 Neoplasms 16 Neuroblastoma 13 Small Cell Lung Carcinoma 12 Carcinoma, Ovarian Epithelial 10 Fallopian Tube Neoplasms 9 Recurrence 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lung Neoplasms 8 Leukemia 8 Uterine Cervical Neoplasms 6 Leukemia, Myeloid, Acute 6 Unspecified Adult Solid Tumor, Protocol Specific 5 Sarcoma, Ewing 5 Neoplasm Metastasis 5 Lymphoma 5 Brain Neoplasms 5 Sarcoma 4 Glioma 4 Endometrial Neoplasms 4 Blast Crisis 4 Rhabdomyosarcoma 3 Medulloblastoma 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Follicular 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Burkitt Lymphoma 3 Brenner Tumor 3 Astrocytoma 3

Interventions

Nivolumab 6 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Paclitaxel 4 Docetaxel 4 Pemetrexed 3 Ipilimumab 3 Erlotinib Hydrochloride 3 Carboplatin 3 ARRY-334543 3 apatinib 2 abemaciclib 2 Vorinostat 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Everolimus 2 Chlorogenic Acid 2 Cetuximab 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 tilsotolimod 1 sargramostim 1 regorafenib 1 ralimetinib 1 prexasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00770731 2013-02-13

Study of Temsirolimus, Topotecan, and Bortezomib

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡